Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedA new revision (v3.6.6) was added to the study's history, replacing the previous revision (v3.6.5) and indicating an update to the record on ClinicalTrials.gov.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe revision history now lists v3.6.5 instead of v3.6.4, reflecting a new interface release. This indicates an update to the ClinicalTrials.gov release notes for the page.SummaryDifference0.1%

- Check38 days agoChange DetectedThe history now shows a new site revision entry, v3.6.4, replacing the previous revision v3.6.3, reflecting an updated release of the interface.SummaryDifference0.1%

- Check60 days agoChange DetectedA new history revision entry (v3.6.3) has been added, replacing the previous revision (v3.6.2) to reflect an updated submission for the study record.SummaryDifference0.1%

- Check67 days agoChange DetectedA new Revision: v3.6.2 was added to the Study Record History and Revision: v3.6.0 was removed, updating the version history to reflect the latest revision.SummaryDifference0.1%

- Check81 days agoChange DetectedThe history now shows that the study is no longer seeking participants. The record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.SummaryDifference0.4%

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.